beta-lactams has been researched along with Skin Diseases, Bacterial in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 18 (81.82) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arguedas, A; Blumer, J; Botet, FA; Cespedes, J; Gesser, R; Snyder, T; Wang, J; West, J; Wimmer, W; Yogev, R | 1 |
| Cohen, R | 1 |
| Cohen, R; Raymond, J | 1 |
| Elliott, DJ; Keren, R; Loh, A; Troxel, AB; Zaoutis, TE | 1 |
| Cabeza, J; Carrasco, C; Gutierrez, J; Sorlozano, A; Villegas, E | 1 |
| Arrigucci, S; Mazzei, T; Novelli, A | 1 |
| Khan, AU; Nordmann, P | 1 |
| Citron, DM; Gesser, RM; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, Y | 1 |
| Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
| Gesser, R; McCarroll, K; Tellado, J; Teppler, H; Woods, GL | 1 |
| Gesser, RM; McCarroll, K; Teppler, H; Woods, GL | 1 |
| DiNubile, MJ; Lipsky, BA | 1 |
| Gesser, RM; Graham, DR; Meibohm, AR; Roy, S; Solomkin, J; Teppler, H; Woods, GL | 1 |
| Gesser, RM; McCarroll, KA; Woods, GL | 1 |
| Brunner, M; Burkhardt, O; Derendorf, H; Grant, M; Schmidt, S; Tang, Y | 1 |
| Falagas, ME; Matthaiou, DK; Vardakas, KZ | 1 |
| Giordano, PA; Jacobs, MR; Jones, RN | 1 |
| Shear, SL | 1 |
| Arata, J; Moritono, S; Saito, A | 1 |
| Chan, JC | 1 |
| Furumoto, H; Mikami, Y; Sasaki, T; Shimizu, T; Tatebayashi, K | 1 |
| Bartizal, K; Gesser, RM; Motyl, M; Pelak, BA; Woods, GL | 1 |
5 review(s) available for beta-lactams and Skin Diseases, Bacterial
| Article | Year |
|---|---|
[Pharmacodynamic and pharmacokinetic of antibiotics for treatment of skin and soft tissue infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Resistance, Bacterial; Fluoroquinolones; Glycopeptides; Humans; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections; Tissue Distribution | 2009 |
Complicated infections of skin and skin structures: when the infection is more than skin deep.
Topics: Adult; Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Lactams; Skin Diseases, Bacterial; Soft Tissue Infections | 2004 |
Fluoroquinolones vs beta-lactams for empirical treatment of immunocompetent patients with skin and soft tissue infections: a meta-analysis of randomized controlled trials.
Topics: Anti-Infective Agents; beta-Lactams; Fluoroquinolones; Humans; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 2006 |
Oral beta-lactams applied to uncomplicated infections of skin and skin structures.
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Humans; Methicillin Resistance; Practice Guidelines as Topic; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Streptococcal Infections | 2007 |
Combating bacterial resistance in skin and skin-structure infection: importance of beta-lactamase inhibition.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Skin Diseases, Bacterial | 1999 |
7 trial(s) available for beta-lactams and Skin Diseases, Bacterial
| Article | Year |
|---|---|
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Child; Child, Preschool; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Humans; Infant; Male; Molecular Sequence Data; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections | 2009 |
General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Double-Blind Method; Enzyme Inhibitors; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Skin Diseases, Bacterial; Tazobactam | 2002 |
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Topics: Abdomen; Adult; Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Surgical Wound Infection | 2002 |
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.
Topics: Abdomen; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enterococcus; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Lactams; Male; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Surgical Wound Infection; Treatment Outcome | 2002 |
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.
Topics: Abdomen; Adolescent; Adult; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Treatment Outcome | 2004 |
Efficacy of ertapenem against methicillin-susceptible Staphylococcus aureus in complicated skin/skin structure infections: results of a double-blind clinical trial versus piperacillin-tazobactam.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Methicillin Resistance; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus aureus | 2004 |
Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Half-Life; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Microdialysis; Muscle, Skeletal; Prospective Studies; Skin Diseases, Bacterial; Subcutaneous Fat; Tissue Distribution | 2006 |
10 other study(ies) available for beta-lactams and Skin Diseases, Bacterial
| Article | Year |
|---|---|
[Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Bone Diseases; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation; Drug Resistance, Bacterial; Forecasting; Humans; Injections, Intravenous; Macrolides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Respiratory Tract Infections; Risk Factors; Skin Diseases, Bacterial; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors | 2008 |
[Bacteriology of cutaneous infections of the child].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Cephalosporins; Child; Drug Resistance, Bacterial; Humans; Macrolides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Methyltransferases; Penicillin G; Penicillin Resistance; Penicillins; Risk Factors; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes | 2008 |
Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Child; Child, Preschool; Clindamycin; Cohort Studies; Drug Therapy, Combination; Emergency Service, Hospital; Empiricism; Female; Hospitalization; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Philadelphia; Retrospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Streptococcal Infections; Streptococcus pyogenes; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2009 |
Antimicrobial development in the era of emerging resistance.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporins; Drug Approval; Drug Resistance, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Pyrimidines; Skin Diseases, Bacterial; Skin Diseases, Viral; Teicoplanin; United States; United States Food and Drug Administration | 2009 |
NDM-1-producing Enterobacter cloacae and Klebsiella pneumoniae from diabetic foot ulcers in India.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Diabetic Foot; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; India; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Skin Diseases, Bacterial; Ulcer | 2012 |
Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Bites and Stings; Fluoroquinolones; Humans; Lactams; Macrolides; Skin Diseases, Bacterial; Tetracyclines | 2002 |
Antimicrobial agents for the dermatologist. I. Beta-lactam antibiotics and related compounds.
Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Penicillins; Skin Diseases, Bacterial; Streptococcal Infections; Syphilis | 1998 |
[Significant role of penem antibiotics: focused on faropenem (discussion)].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Lactams; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1997 |
Profound skin infection with bone involvement due to Nocardia asteroides in a patient with myelodysplastic syndrome.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Bone Diseases, Infectious; Female; Foot; Humans; Lactams; Magnetic Resonance Imaging; Myelodysplastic Syndromes; Nocardia asteroides; Nocardia Infections; Skin Diseases, Bacterial | 2001 |
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.
Topics: Aerobiosis; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lactams; Microbial Sensitivity Tests; Skin Diseases, Bacterial | 2002 |